Bluejay Investor Presentation Deck
Symphony™M IL-6 Test: Platform Potential for Rapid Results in Critical Care Settings
Quantitative determination of IL-6 by fluorescence enzyme immunoassay from whole blood specimens
●●●
bluejay
DIAGNOSTICS
Measuring IL-6 could help medical professionals make earlier and actionable
treatment decisions.
Rapid turnaround time crucial as 'time is the enemy' in critical care settings.
Interleukin-6 (IL-6) is an Early Responder Biomarker During Trauma or Infection. Important in:
Sepsis And Covid-19
Cardiovascular Diseases
Autoimmune Disorders
The Symphony™ System and SymphonyTM Cartridge have not been cleared or approved by the U.S. FDA
Multi-organ-Failure
Acute Respiratory Distress Syndrome (ARDS)
Infectious Disease
Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | August 2023 9View entire presentation